AU3023999A - Use of 3,4-diphenylchromans for the manufacture of a pharmaceutical composition for lowering plasma levels of lp(a) in a human or sub-human primate - Google Patents

Use of 3,4-diphenylchromans for the manufacture of a pharmaceutical composition for lowering plasma levels of lp(a) in a human or sub-human primate

Info

Publication number: AU3023999A
Authority: AU; Australia
Prior art keywords: human; diphenylchromans; sub; manufacture; pharmaceutical composition
Prior art date: 1998-03-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU30239/99A

Inventor

Birgitte Hjort Guldhammer

Niels Korsgaard

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novo Nordisk AS

Original Assignee

Novo Nordisk AS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-20

Filing date

1999-03-17

Publication date

1999-10-18

1999-03-17 Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS

1999-10-18 Publication of AU3023999A publication Critical patent/AU3023999A/en

Status Abandoned legal-status Critical Current

Links

241000288906 Primates Species 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
230000036470 plasma concentration Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU30239/99A 1998-03-20 1999-03-17 Use of 3,4-diphenylchromans for the manufacture of a pharmaceutical composition for lowering plasma levels of lp(a) in a human or sub-human primate Abandoned AU3023999A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DK394/98		1998-03-20
DK39498		1998-03-20
PCT/DK1999/000139 WO1999048497A1 (en)	1998-03-20	1999-03-17	USE OF 3,4-DIPHENYLCHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR LOWERING PLASMA LEVELS OF Lp(a) IN A HUMAN OR SUB-HUMAN PRIMATE

Publications (1)

Publication Number	Publication Date
AU3023999A true AU3023999A (en)	1999-10-18

Family

ID=8093022

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU30239/99A Abandoned AU3023999A (en)	1998-03-20	1999-03-17	Use of 3,4-diphenylchromans for the manufacture of a pharmaceutical composition for lowering plasma levels of lp(a) in a human or sub-human primate

Country Status (2)

Country	Link
AU (1)	AU3023999A (en)
WO (1)	WO1999048497A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5407955A (en) *	1994-02-18	1995-04-18	Eli Lilly And Company	Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
JPH10511961A (en) *	1995-01-13	1998-11-17	ノボノルディスクアクティーゼルスカブ	3,4-diphenyl for the treatment or prevention of hyperlipoproteinemia, hypertriglyceridemia, hyperlipidemia or hypercholesterolemia, or for the manufacture of a pharmaceutical composition for anticoagulation treatment Use of chroman

1999
- 1999-03-17 AU AU30239/99A patent/AU3023999A/en not_active Abandoned
- 1999-03-17 WO PCT/DK1999/000139 patent/WO1999048497A1/en active Application Filing

Also Published As

Publication number	Publication date
WO1999048497A1 (en)	1999-09-30

Similar Documents

Publication	Publication Date	Title
AU1450900A (en)	2000-05-08	Methods of treatment of type 2 diabetes
AU2480499A (en)	1999-08-16	Calcification-resistant medical articles
AU2317699A (en)	2000-01-10	Dental restoratives
AU4060599A (en)	1999-12-30	Pharmaceutical composition for treating or preventing sleep disorders
AUPP370198A0 (en)	1998-06-18	Control of the administration of continuous positive airway pressure treatment
AU2002306269A1 (en)	2003-05-15	N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
AU1818100A (en)	2000-05-29	Desktop projection monitor
AU2000276362A1 (en)	2002-01-21	Composition for the treatment of diabetes
AU2001284413A1 (en)	2002-03-13	Medicinal compositions for preventing or treating heart failure
AU1367597A (en)	1997-08-01	Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of benign prostatic hypertrophy
IL139531A0 (en)	2001-11-25	Human antithrombin iii, methods for the production thereof and pharmaceutical compositions containing the same
AU3814599A (en)	1999-11-01	Use of erythropoietin for the treatment of haemochromatoses
AU768217C (en)	2005-04-21	2-methylpropionic acid derivatives and medicinal compositions containing the same
AU4328996A (en)	1996-08-07	Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
AUPP332898A0 (en)	1998-05-28	Pharmaceutical composition
AU3059795A (en)	1996-03-28	Cosmetic composition which prevents or attenuates the photo-reactivity of titanium dioxide nanopigments
AU4329096A (en)	1996-07-31	Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia
AU3023999A (en)	1999-10-18	Use of 3,4-diphenylchromans for the manufacture of a pharmaceutical composition for lowering plasma levels of lp(a) in a human or sub-human primate
AU5055799A (en)	2000-02-14	Dermatological compositions for the treatment of scars
AU4329196A (en)	1996-08-07	Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
AU4107797A (en)	1998-12-11	Compounds for the treatment and prevention of diabetes
AU3071899A (en)	1999-09-20	Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma
IL146812A0 (en)	2002-07-25	Streptogramin derivatives, production thereof and compositions containing the same
AU3171099A (en)	1999-11-08	1-heteroindene derivatives and medicinal composition containing the same
AU4475300A (en)	2000-11-10	Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression

Legal Events

Date	Code	Title	Description
2000-12-07	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase